| 今开：5.04 | 昨收：5.05 |
| 最高：5.155 | 最低：5.02 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.36104409E8 |
Aurinia(AUPH)02-15 19:25
$Aurinia制药(AUPH)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001600620-24-000012 Act: 34 Size: 12 MB 网页链接查看全文
卢克和贝塔01-25 23:00
$Aurinia制药(AUPH)$ 现在可能是不错的买入机会。AUR 200/AUR 300在稳定的推进，当前有可靠的现金流，可靠的产品，和不错的团队。此外降息环境，医院行业也可能出现更多的收并购机会。$生科3X做多-Direxion(LABU)$查看全文
Aurinia(AUPH)03-01 05:15
$Aurinia制药(AUPH)$ 8-K Current report, item 5.02 Accession Number: 0001600620-24-000027 Act: 34 Size: 151 KB 网页链接查看全文
SeekingBiotech02-16 22:44
AUPH concluded its strategic review that began in June 2023 but failed to attract any formal offers, confirming a Reuters report on Thursday$Aurinia制药(AUPH)$ 报价要合理，可能错过了卖出机会。查看全文
Aurinia(AUPH)02-23 05:25
$Aurinia制药(AUPH)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000015 Size: 4 KB 网页链接查看全文
Aurinia(AUPH)02-23 05:25
$Aurinia制药(AUPH)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000014 Size: 4 KB 网页链接查看全文
Aurinia(AUPH)02-23 05:35
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000020 Size: 5 KB 网页链接查看全文
Aurinia(AUPH)03-08 05:45
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000034 Size: 5 KB 网页链接查看全文
Aurinia(AUPH)03-08 05:55
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000037 Size: 5 KB 网页链接查看全文
智通财经APP获悉，英国制药集团葛兰素史克(GSK.US)周一驳斥了《星期日邮报》(Mail on Sunday)的一篇报道，该报道称，葛兰素史克可能有意竞购自身免疫性疾病药物开发商Aurinia Pharmaceuticals(AUPH.US)。 葛兰素史克的发言人表示，该报... 网页链接
凤凰网港股|Aurinia制药公司(AUPH)宣布，该公司的许可合作伙伴大冢制药公司（OPEL）向欧洲药品管理局（EMA）提交了用于治疗狼疮性肾炎（LN）的voclosporin的首次上市授权申请（MAA）。 狼疮是自身免疫性疾病系统性红斑狼疮（SLE）的一种并发... 网页链接
$Aurinia制药(AUPH)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-036780 Act: 34 Size: 150 KB 网页链接
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000037 Size: 5 KB 网页链接
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000038 Size: 5 KB 网页链接
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000035 Size: 5 KB 网页链接
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000034 Size: 5 KB 网页链接
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000036 Size: 5 KB 网页链接
$Aurinia制药(AUPH)$ 8-K Current report, item 5.02 Accession Number: 0001600620-24-000027 Act: 34 Size: 151 KB 网页链接
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000028 Size: 4 KB 网页链接
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000022 Size: 5 KB 网页链接
$Aurinia制药(AUPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001600620-24-000017 Size: 5 KB 网页链接